Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Advanta Sample ID Genotyping Panel

Fluidigm has launched the Advanta Sample ID Genotyping Panel for the identification and quality assessment of human samples and cell lines in disease research. Developed for use with the Biomark HD system, the Advanta panel enables laboratories to accurately detect a unique genetic fingerprint from samples at each stage of their journey. The panel design contains 96 different SNP variants, including 80 synonymous human variants located in exonic regions of the genome; 10 quality assessment variants; and six gender-confirming variants. New targets for specific sample populations also can be added to customize the panel based on specific study goals, Fluidigm noted.


The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.